Fistulizing Crohn's disease

被引：10
|
作者：
Felley, C
Mottet, C
Juillerat, P
Froehlich, F
Burnand, B
Vader, JP
Michetti, P
Gonvers, JJ
机构：
[1] Univ Lausanne, Med Ctr, Div Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland
[2] Univ Basel, Gastrointestinal Dept, Basel, Switzerland
[3] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland
来源：
DIGESTION | 2005年 / 71卷 / 01期
关键词：
Crohn's disease; fistula; antibiotics; azathioprine; infliximab; methotrexate; cyclosporine; tacrolimus; internal fistulas; surgery;
D O I：
10.1159/000083868
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%). Medical therapy is the main option for perianal fistula once abscesses, if present, have been drained, and should include antibiotics ( both ciprofloxacin and metronidazole) and immunomodulators. Infliximab should be reserved for refractory patients. Surgery is often necessary for internal fistulas. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [31] Treatment of luminal and fistulizing Crohn's disease with infliximab
    Comerford, LW
    Bickston, SJ
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 387 - +
  • [32] CROHN'S DISEASE How modern is the management of fistulizing disease?
    Fichera, Alessandro
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (09) : 511 - 512
  • [33] Infliximab maintenance therapy for fistulizing Crohn's disease
    Brechmann, T
    MEDIZINISCHE KLINIK, 2006, 101 (05) : 423 - 424
  • [34] Fistulizing Crohn's Disease: A Case of Mistaken Identity
    Mukherjee, Aparna K.
    McDevitt, Patrick J.
    Le, Tri H.
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (02) : 66 - 71
  • [35] Guidelines for Imaging of Crohn's Perianal Fistulizing Disease
    Ong, Eugene M. W.
    Ghazi, Leyla J.
    Schwartz, David A.
    Mortele, Koenraad J.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (04) : 731 - 736
  • [36] Infliximab maintenance therapy for fistulizing Crohn's disease
    Sands, BE
    Anderson, FH
    Bernstein, CN
    Chey, WY
    Feagan, BG
    Fedorak, RN
    Kamm, MA
    Korzenik, JR
    Lashner, BA
    Onken, JE
    Rachmilewitz, D
    Rutgeerts, P
    Wild, G
    Wolf, DC
    Marsters, PA
    Travers, SB
    Blank, MA
    van Deventer, SJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09): : 876 - 885
  • [37] Racial Differences in Fistulizing Perianal Crohn's Disease
    Alli, Latifat
    Hadi, Nicole
    Patel, Pruthvi
    Sachar, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S651 - S652
  • [38] Management of fistulizing Crohn's disease:: the conservative approach
    Hamzaoglu, H. Oe
    IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 245 - 248
  • [39] Preclinical Model of Perianal Fistulizing Crohn's Disease
    Flacs, Meredith
    Collard, Maxime
    Doblas, Sabrina
    Zappa, Magaly
    Cazals-Hatem, Dominique
    Maggiori, Leon
    Panis, Yves
    Treton, Xavier
    Ogier-Denis, Eric
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (05) : 687 - 696
  • [40] Role of infliximab in the treatment of fistulizing Crohn's disease
    Karmiris, K.
    Koutroubakis, I. E.
    ANNALS OF GASTROENTEROLOGY, 2005, 18 (03): : 297 - 302
12345